Results analysis from Kepler Trust Intelligence

RNS Number : 6845V

BH Macro Limited

06 April 2023

 

BH Macro (BHMG)

06/04/2023

Results analysis from Kepler Trust Intelligence

Brevan Howard Capital Management LP (the "Manager") achieved excellent returns in 2022 during a turbulent period in markets, the global economy and geopolitics. The NAV per share rose by 21.91% for the Sterling share class, which were impressive relative returns compared with other asset classes. In the Chair, Richard Horlick's, view this absolute and relative performance makes BH Macro Limited a cornerstone in investors' portfolios.

Coming into 2023, hopes that a soft landing would be achieved hit the skids in March when the Fed and the ECB turned more hawkish on inflation and unleashed a cascade of bank failures and retrenchments. The board is wholly independent of the Brevan Howard group and maintains a regular dialogue with the manager in order to assure itself of the quality of the investment team and supporting systems, operations and infrastructure across the organisation. BH Macro's Chair states that he believes that the trading team today is the strongest it has ever been.

Brevan Howard observe that global imbalances, both within individual economies as well as between them, in part due to economic desynchronisation, are at generational extremes. As a consequence, the macro landscape looks set to remain extremely interesting.

Kepler View

BH Macro invests all of its capital into the Brevan Howard Master Fund, the flagship hedge fund run by Brevan Howard. 2022 proved a banner year for BH Macro, delivering exactly as shareholders would have hoped by achieving a strong NAV return at a time when the rest of their portfolio was having a significantly tougher time. Importantly, the share price remained firm throughout this period, and the sterling shares traded at an average premium of 10.6% during the year, enabling the board to issue shares worth c. £185m.

More recently March 2023 was a tough month. As at 31st March 2023 the estimated Net Asset Values was 404p, reflecting a decline of 4.33% over the month, and -3.45% over the calendar year to date. We observe that many other macro hedge fund strategies have also fallen significantly, many having been negatively influenced by the very significant move in US interest rate expectations that followed the collapse in Silicon Valley Bank.

The negative performance during March has unsurprisingly taken some of the shine off the share price rating, having retreated to a modest premium to NAV of 3.9% (as at 06/04/2023).

CLICK HERE TO READ THE FULL REPORT 

Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

END

 

 

NRASSWFLMEDSEIL